Clinical Trial Update: An Open-label Study to Evaluate Topiramate Therapy in Migraine Patients, and Its Effects on Subject Responsiveness to Migraine Treatment With Triptans [Phase 2]

View source ↗

Summary

Phase 2 open-label study evaluating topiramate for migraine and its effects on responsiveness to triptan therapy has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Migraine

Drugs mentioned

• Topamax (Topiramate)

Snippet

Sponsor: Janssen-Ortho Inc., Canada | Conditions: Headache | Phase 2 | Status: COMPLETED